Considerations in retransplantation of the failed renal allograft recipient

Advances in Chronic Kidney Disease

Volumn 13, Issue 1, 2006, Pages 18-28

  Koch, Matthew J ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Allograft; Evaluation; Kidney; Outcomes; Retransplantation

Indexed keywords

ALEMTUZUMAB; CALCINEURIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; POLYCLONAL ANTIBODY; RAPAMYCIN; CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE;

CHRONIC KIDNEY DISEASE; COMORBIDITY; DIABETES MELLITUS; DIALYSIS; DOSE RESPONSE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; LIVING DONOR; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL GRAFT DYSFUNCTION; RETRANSPLANTATION; REVIEW; TREATMENT OUTCOME; ADULT; ANAMNESIS; ARM WEAKNESS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISABILITY; DISABILITY SEVERITY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; LIMB WEAKNESS; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PHYSICAL EXAMINATION; RECURRENT DISEASE; SCORING SYSTEM; CLINICAL TRIAL; MIDDLE AGED; TREATMENT FAILURE;

DECISION MAKING; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; RETREATMENT; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; ADRENAL CORTEX HORMONES; DISABILITY EVALUATION; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE;

EID: 33646379131     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200601000-00006     Document Type: Review

References (33)

1. R.A. Wolfe, V.B. Ashby, E.L. Milford Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant N Engl J Med 341 1999 1725 1730
2. H.U. Meier-Kriesche, F.K. Port, A.O. Ojo Effect of waiting time on renal transplant outcome Kidney Int 58 2000 1311 1317
3. H.U. Meier-Kriesche, B. Kaplan Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes A paired donor kidney analysis Transplantation 74 2002 1377 1381
4. H.U. Meier-Kriesche, J.D. Schold, B. Kaplan Long-term renal allograft survival Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4 2004 1289 1295
5. U.S. Renal Data System USRDS 2004 Annual Data Report Atlas of End-Stage Renal Disease in the United States 2004 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
6. 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI.
7. D.L. Raju, V.K. Grover, A. Shoker Limitations of glomerular filtration rate equations in the renal transplant patient Clin Transplant 19 2005 259 268
8. F. Vincenti, G.M. Ghiggeri New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis Am J Transplant 5 2005 1179 1185
9. J. Pinto, G. Lacerda, J.S. Cameron Recurrence of focal segmental glomerulosclerosis in renal allografts Transplantation 32 1981 83 89
10. E. Stephanian, A.J. Matas, S.M. Mauer Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis Transplantation 53 1992 755 757
11. G.L. Bumgardner, W.C. Amend, N.L. Ascher Single-center long-term results of renal transplantation for IgA nephropathy Transplantation 65 1998 1053 1060
12. C. Ohmacht, V. Kliem, M. Burg Recurrent immunoglobulin A nephropathy after renal transplantation A significant contributor to graft loss Transplantation 64 1997 1493 1496
13. P. Freese, C. Svalander, G. Norden Clinical risk factors for recurrence of IgA nephropathy Clin Transplant 13 1999 313 317
14. Y.S. Kim, J.I. Moon, H.J. Jeong Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy Transplantation 71 2001 233 238
15. P.P. Frohnert, J.V. Donadio Jr, J.A. Velosa The fate of renal transplants in patients with IgA nephropathy Clin Transplant 11 1997 127 133
16. C. Ponticelli, L. Traversi, A. Feliciani Kidney transplantation in patients with IgA mesangial glomerulonephritis Kidney Int 60 2001 1948 1954
17. A.Y. Wang, F.M. Lai, A.W. Yu Recurrent IgA nephropathy in renal transplant allografts Am J Kidney Dis 38 2001 588 596
18. J.M. Cruzado Recurrent glomerulonephritis and risk of renal allograft loss N Engl J Med 347 2002 1531 1532
19. E. Ramos, F. Vincenti, W.X. Lu Retransplantation in patients with graft loss caused by polyoma virus nephropathy Transplantation 77 2004 131 133
20. F. Ginevri, N. Pastorino, R. de Santis Retransplantation after kidney graft loss due to polyoma BK virus nephropathy Successful outcome without original allograft nephrectomy Am J Kidney Dis 42 2003 821 825
21. A. Ojo, R.A. Wolfe, L.Y. Agodoa Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation Multivariate analyses from the United States Renal Data System Transplantation 66 1998 1651 1659
22. B. Kaplan, H.U. Meier-Kriesche Death after graft loss An important late study endpoint in kidney transplantation Am J Transplant 2 2002 970 974
23. P.S. Rao, D.E. Schaubel, R. Saran Impact of graft failure on patient survival on dialysis A comparison of transplant-naive and post-graft failure mortality rates Nephrol Dial Transplant 20 2005 387 391
24. R.S. Sung, M.K. Guidinger, C.D. Lake Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys Transplantation 79 2005 1257 1261
25. M.T. Sellers, E. Velidedeoglu, R.D. Bloom Expanded-criteria donor kidneys A single-center clinical and short-term financial analysis - cause for concern in retransplantation Transplantation 78 2004 1670 1675
26. F.G. Cosio, Y. Kudva, M. van der Velde New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation Kidney Int 67 2005 2415 2421
27. A. Karras, E. Thervet, Y. Le Meur Successful renal retransplantation after post-transplant lymphoproliferative disease Am J Transplant 4 2004 1904 1909
28. A.C. Farney, A.J. Matas, H.J. Noreen Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival? Clin Transplant 10 1996 147 156
29. S.C. Jordan, A. Vo, S. Bunnapradist Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients Transplantation 76 2003 631 636
30. R.A. Montgomery, A.A. Zachary, L.C. Racusen Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 70 2000 887 895
31. E. Akalin, S. Ames, V. Sehgal Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients Transplantation 76 2003 1444 1447
32. J.M. Gloor, D.J. Lager, S.B. Moore ABO-incompatible kidney transplantation using both A2 and non-A2 living donors Transplantation 75 2003 971 977
33. K. Takahashi, K. Saito, S. Takahara Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan Am J Transplant 4 2004 1089 1096